By Chris Wack
Nano-X Imaging shares rose after the company received 510(k) clearance from the Food and Drug Administration for its Nanox.ARC, a stationary X-ray system intended for adult patients.
Shares were up 10% to $6.90 in recent trading. The stock is up almost 7% this year.
The medical imaging technology company said its Nanox.ARC uses advanced tomosynthesis technology to create a more comprehensive, sliced three-dimensional view of the body.
The Israeli company believes the new FDA-cleared indications will help broaden Nanox. ARC's commercial expansion in the U.S., where it is currently deployed in seven states.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
December 05, 2024 10:48 ET (15:48 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments